Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Armata Pharmaceuticals, Inc. (ARMP) stock rallied over 6.28% intraday to trade at $3.89 a share on AMEX. The stock opened with a gain of 5.99% at $3.89 and touched an intraday high of $3.89, rising 6.28% against the last close of $3.66. The stock went to a low of $3.89 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-30 | $3.89 | $3.89 | $3.89 | $3.89 | 480 |
2022-06-29 | $3.67 | $3.69 | $3.66 | $3.66 | 2,100 |
2022-06-28 | $4.05 | $4.05 | $3.58 | $3.94 | 1,600 |
2022-06-27 | $3.67 | $3.91 | $3.46 | $3.65 | 5,300 |
2022-06-24 | $3.73 | $3.73 | $3.35 | $3.35 | 3,400 |
2022-06-23 | $3.1 | $3.77 | $3.1 | $3.35 | 12,200 |
2022-06-22 | $3.55 | $3.59 | $2.97 | $2.97 | 6,700 |
2022-06-21 | $3.62 | $3.86 | $3.38 | $3.38 | 21,500 |
2022-06-17 | $3.75 | $3.86 | $3.62 | $3.62 | 12,000 |
2022-06-16 | $3.82 | $4.21 | $3.77 | $3.77 | 5,600 |
Employees-
Beta1.13
Sales or Revenue4.47 Million
5Y Sales Change76.70%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Armata Pharmaceuticals, Inc. (AMEX: ARMP) stock price is $3.89 as of the last check on Thursday, June 30. During the trading session, ARMP stock reached the peak price of $3.89 while $3.89 was the lowest point it dropped to.
The AMEX listed ARMP is part of Biotechnology industry that operates in the broader Health Care sector. Armata Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.
Dr. Brian Varnum Ph.D.
CEO & Director
Mr. Steven R. Martin
Sr. VP, CFO and Principal Financial & Accounting Officer
Mr. Todd R. Patrick MBA
Advisor & Director
Dr. Wenyuan Shi Ph.D.
Co-Founder & Founding Scientist
ARMP stock traded closed the last session at $3.89, which is $0.23 or 6.28% lower than its previous close of $3.66. ARMP's current trading price is 37.94% lower than its 52-week high of $6.49 where as its distance from 52-week low of 2.82% is -40.06%.
Number of ARMP employees currently stands at -. ARMP operates from 4503 Glencoe Avenue, Marina del Rey, CA 90292, United States.
Official Webiste of $ARMP is: https://www.armatapharma.com
ARMP could be contacted at ARMP operates from 4503 Glencoe Avenue, Marina del Rey, CA 90292, United States, or at phone #858 829 0829 and can also be accessed through its website.
ARMP stock volume for the day was 480 shares while in the previous session number of ARMP shares traded was 480 . The average number of ARMP shares traded daily for last 3 months was 6.67 Thousands.
The percentage change in ARMP stock occurred in the recent session was 6.28% while the dollar amount for the price change in ARMP stock was $0.23.
In the recent session, the day high for ARMP stock was $3.89 while the low for ARMP stock touched on the day was $3.89.
The market value of ARMP currently stands at 140.51 Million with its latest stock price at $3.89 and 29 Million of its shares outstanding.